Janux Therapeutics, Inc.
JANX
$24.37
$1.104.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.01B | 1.03B | 658.03M | 646.29M | 651.76M |
| Total Receivables | 5.59M | 5.38M | 4.45M | 12.06M | 4.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.61M | 3.11M | 3.84M | 3.59M | 2.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02B | 1.03B | 666.32M | 661.94M | 658.67M |
|
|
|||||
| Total Current Assets | 1.02B | 1.03B | 666.32M | 661.94M | 658.67M |
| Net Property, Plant & Equipment | 23.83M | 24.15M | 25.06M | 26.02M | 26.98M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.61M | 3.70M | 3.64M | 3.46M | 3.34M |
| Total Assets | 1.05B | 1.06B | 695.02M | 691.41M | 688.98M |
|
|
|||||
| Total Accounts Payable | 2.35M | 4.03M | 2.46M | 1.25M | 2.25M |
| Total Accrued Expenses | 13.34M | 11.68M | 13.02M | 8.57M | 5.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81M | 1.75M | 1.69M | 1.63M | 1.57M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 94.00K | 972.00K |
| Total Other Current Liabilities | -- | -- | -- | 94.00K | 972.00K |
| Total Current Liabilities | 17.50M | 17.46M | 17.17M | 11.55M | 10.61M |
|
|
|||||
| Total Current Liabilities | 17.50M | 17.46M | 17.17M | 11.55M | 10.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.80M | 21.28M | 21.74M | 22.19M | 22.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.30M | 38.74M | 38.92M | 33.74M | 33.22M |
|
|
|||||
| Common Stock & APIC | 1.27B | 1.26B | 865.81M | 848.78M | 839.81M |
| Retained Earnings | -261.27M | -237.76M | -217.54M | -189.48M | -183.52M |
| Treasury Stock & Other | 3.76M | 2.16M | 7.83M | -1.62M | -524.00K |
| Total Common Equity | 1.01B | 1.02B | 656.10M | 657.68M | 655.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.01B | 1.02B | 656.10M | 657.68M | 655.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.01B | 1.02B | 656.10M | 657.68M | 655.76M |
|
|
|||||